â– LECTURE OVERVIEW: Optic disc cupping is the physical manifestation of progressive retinal ganglion cell axonal apoptosis caused by chronic open-angle glaucoma.
â– MOLECULAR AND PHYSICAL MECHANICAL TRACTION:
1. Ganglion Axons: Retinal Ganglion Cells (RGCs) project their axons across the retina, gathering at the optic disc before exiting the sclera as the optic nerve.
2. High Intrabulbar Tension: Chronic elevations in intraocular pressure (IOP) generate mechanical shearing forces.
3. Lamina Cribrosa Compression: Shearing forces compress the lamina cribrosa, a sieve-like collagenous plate at the back of the eye.
4. Axoplasmic Blockage: Compression of the lamina blocks orthograde and retrograde axonal transport of essential neurotrophin factors (e.g., BDNF) in RGC axons.
5. Axonal Atrophy: Deprived of neurotrophins, RGCs undergo apoptotic cell death, leading to progressive thinning of the neuroretinal rim and widening of the central cup (the cup-to-disc ratio expands beyond a normal 0.3 to over 0.7).
â– THERAPEUTIC TARGETS & MANAGEMENT:
Primary pharmacological intervention aims to restore physiological homeostatic balance. This is achieved by either competitively blocking receptor sites, allosterically inhibiting enzymes, or supplementing missing metabolic products.
â– CLINICAL REGISTRY INSIGHTS:
Patient registry reviews depict high clinical validity in diverse populations, indicating highly correlated trends of symptom development and treatment responsiveness.
[HY-BOARD-1004]
🌟 Dynamic Clinical Key:
Optic disc cupping correlates with predictable visual field defects. Losses begin in the mid-periphery as nasal steps or arcuate scotomas, before contracting into peripheral 'tunnel vision', sparing central visual acuity until the end stages. Absolute contraindications include pregnancy, renal insufficiency, or concurrent use of metabolic inhibitors. Assess demographic representation when applying trial results to real-world patients.